Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling

Slides:



Advertisements
Similar presentations
Volume 14, Issue 4, Pages (October 2008)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 24, Issue 5, Pages (May 2006)
Volume 43, Issue 6, Pages (December 2015)
Volume 44, Issue 6, Pages (June 2016)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 25, Issue 6, Pages (December 2006)
Volume 28, Issue 2, Pages (February 2008)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 31, Issue 2, Pages (August 2009)
Volume 23, Issue 6, Pages (December 2005)
Volume 41, Issue 6, Pages (December 2014)
Volume 30, Issue 3, Pages (March 2009)
Volume 22, Issue 5, Pages (May 2012)
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Volume 38, Issue 4, Pages (April 2013)
Volume 18, Issue 5, Pages (May 2003)
Volume 26, Issue 2, Pages (February 2007)
Volume 36, Issue 5, Pages (May 2012)
Volume 36, Issue 1, Pages (January 2012)
Volume 35, Issue 6, Pages (December 2011)
The UPEC Pore-Forming Toxin α-Hemolysin Triggers Proteolysis of Host Proteins to Disrupt Cell Adhesion, Inflammatory, and Survival Pathways  Bijaya K.
Volume 47, Issue 5, Pages e6 (November 2017)
Volume 39, Issue 5, Pages (November 2013)
Volume 35, Issue 1, Pages (July 2011)
Volume 29, Issue 2, Pages (August 2008)
Volume 31, Issue 2, Pages (August 2009)
Volume 27, Issue 1, Pages (July 2007)
Volume 42, Issue 4, Pages (April 2015)
Double-Stranded RNA-Mediated TLR3 Activation Is Enhanced by CD14
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 24, Issue 5, Pages (May 2006)
Volume 34, Issue 1, Pages (January 2011)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 22, Issue 4, Pages (April 2005)
Volume 39, Issue 4, Pages (October 2013)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 22, Issue 3, Pages (March 2005)
Volume 31, Issue 5, Pages (November 2009)
Volume 37, Issue 6, Pages (December 2012)
Volume 34, Issue 3, Pages (March 2011)
Volume 38, Issue 2, Pages (February 2013)
Volume 25, Issue 5, Pages (November 2006)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 33, Issue 4, Pages (October 2010)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 38, Issue 3, Pages (March 2013)
Volume 32, Issue 4, Pages (April 2010)
Volume 15, Issue 2, Pages (February 2014)
Volume 25, Issue 5, Pages (November 2006)
Volume 35, Issue 2, Pages (August 2011)
Volume 21, Issue 6, Pages (November 2017)
Volume 33, Issue 5, Pages (November 2010)
Volume 43, Issue 4, Pages (October 2015)
Volume 30, Issue 6, Pages (June 2009)
Volume 42, Issue 4, Pages (April 2015)
Volume 40, Issue 4, Pages (April 2014)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 68, Issue 3, Pages e5 (November 2017)
Volume 38, Issue 2, Pages (February 2013)
Volume 28, Issue 3, Pages (March 2008)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 24, Issue 1, Pages (January 2006)
Volume 46, Issue 2, Pages (April 2012)
Volume 156, Issue 4, Pages (February 2014)
Volume 31, Issue 5, Pages (November 2009)
Suman Paul, Anuj K. Kashyap, Wei Jia, You-Wen He, Brian C. Schaefer 
Volume 28, Issue 1, Pages (January 2008)
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling Boyoun Park, Ludovico Buti, Sungwook Lee, Takashi Matsuwaki, Eric Spooner, Melanie M. Brinkmann, Masugi Nishihara, Hidde L. Ploegh  Immunity  Volume 34, Issue 4, Pages 505-513 (April 2011) DOI: 10.1016/j.immuni.2011.01.018 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Granulin Interacts with TLR9 (A) SDS-PAGE of anti-Myc immunoprecipitates prepared from RAW macrophages that stably expressed Myc-tagged wild-type TLR9 (TLR9-Myc), treated for 12 hr with DMSO or 20 μM z-FA-fmk, metabolically labeled for 2 hr, and chased for 6 hr. TLR9 recovered by immunoprecipitation with anti-Myc was treated with peptide:N-glycosidase F to remove N-linked glycans. The asterisk indicates polypeptides that are recovered specifically in association with TLR9-Myc. (B) RAW macrophages expressing TLR9-Myc were treated with DMSO or 20 μM z-FA-fmk for 12 hr. Anti-Myc immunoprecipitates were resolved by SDS-PAGE and visualized by silver staining. Granulin sequences identified by LC-MS-MS are indicated by the gray bars. Data are representative of three (A) and two (B) independent experiments. Immunity 2011 34, 505-513DOI: (10.1016/j.immuni.2011.01.018) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 TLR9 Signaling but Not Proteolytic Cleavage Is Impaired by Elastase Inhibitor (A) RAW macrophages were treated with DMSO, 20 μM z-FA-fmk, or 100 μM elastase inhibitor for 12 hr, followed by stimulation with 10 μM poly(I:C) (TLR3), 10 ng/ml LPS (TLR4), 10 μg/ml Imiquimod (TLR7), or 1 μM CpG-B (TLR9) for 2 hr. Cytokine production was measured by ELISA. (B) RAW macrophages expressing TLR9-Myc were incubated with DMSO, 20 μM z-FA-fmk, or 100 μM elastase inhibitor for 12 hr. Cells were immunoprecipitated with a Myc-specific antibody. N-linked glycans were eliminated by digestion with Endo F. Immunoprecipitated proteins were immunoblotted by a Myc-antibody. Data are representative of three independent experiments (average and SEM in A). Immunity 2011 34, 505-513DOI: (10.1016/j.immuni.2011.01.018) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Granulin Augments the TLR9 Response (A) RAW macrophages were stimulated for 2 hr with 10 μM poly(I:C), 10 μg/ml Imiquimod, and 1 μM CpG-A, -B, or -C (top), or with 150 nM poly(I:C), 150 ng/ml Imiquimod, and 15 nM CpG-A, -B, or -C (bottom) in serum-free medium with or without the addition of purified granulin (100 ng). Secreted TNF-α was analyzed by ELISA. (B) Granulin was depleted by immunoprecipitation with a granulin-specific antibody. After several rounds of depletion, the absence of granulin was verified by immunoblot with anti-granulin. RAW macrophages were then stimulated with 1 μM of CpG-B in depleted or control supernatants for the indicated times. Cells were washed with serum-free medium and incubated for 4 hr with fresh serum-free medium containing 10 μg/ml brefeldin A. Cells were fixed and stained with anti-TNF-α and intracellular TNF-α was measured by flow cytometry. TNF expression is presented as mean fluorescence intensity (MFI). (C) BMDM from WT or Grn–/– mice were cultured for 7 days in BMDM medium with M-CSF. Cells were transferred to serum-free medium and washed several times to remove any remaining serum-derived granulin. BMDM were stimulated with 10 μM poly(I:C), 10 μg/ml Imiquimod, and 1 μM CpG-B or -C for 4 hr. TNF-α and IL-6 were measured by ELISA. Data are representative of three independent experiments (average and SEM). Immunity 2011 34, 505-513DOI: (10.1016/j.immuni.2011.01.018) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Granulin Binds to Different Types of ODNs (A) RAW macrophages were incubated with 1 μM Biotin-CpG-B in serum-free medium for the indicated times. Biotinylated CpG-B was recovered on streptavidin beads, and bound materials were analyzed by immunoblot with a granulin antibody. (B) RAW macrophages were incubated with 2 μM biotinylated CpG-A, -B, -C, or inhibitory ODNs in serum-free medium for the indicated times. Biotinylated ODNs were recovered by streptavidin beads, and then binding of granulin to ODNs was examined by immunoblot with anti-granulin. Data are representative of three independent experiments. Immunity 2011 34, 505-513DOI: (10.1016/j.immuni.2011.01.018) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 Granulin Potentiates TLR9 Activation through Enhanced Delivery of CpG-ODNs (A) BMDM from WT or Grn–/– mice were stimulated with 1 μM Alexa 647 CpG-B in the presence or absence of purified granulin (100 ng). Nuclei were stained with Dapi (150 nM). Cells were incubated in serum-free medium for 48 hr and washed several times to remove any remaining serum-derived granulin. Intracellular localization of CpG-B was analyzed by confocal microscopy. Scale bar represents 10 μm. Bound CpG-ODNs to cells were quantified counting the fluorescent cells. (B) Raw macrophages were stimulated with 1 μM Alexa 647-labeled CpG-B (red) in the presence or absence of purified Alexa 488-labeled granulin (100 ng) (green). SDS-PAGE characterization of Alexa 488-labeled granulin with coomassie staining or by fluorescent gel scanning. Scale bar represents 10 μm. Data are representative of three independent experiments. Immunity 2011 34, 505-513DOI: (10.1016/j.immuni.2011.01.018) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 6 Granulin Is Essential for Interaction of TLR9 with CpG-ODNs (A) BMDM from WT or Grn–/– mice were cultured for 7 days in BMDM medium with M-CSF. Cells were transferred to serum-free medium and transduced with a retrovirus encoding the recombinant Myc-tagged C-terminal TLR9 fragment for 24 hr. Cells were incubated with 3 μM Biotin-CpG-B and dose-dependent concentrations of purified granulin in serum-free medium for 4 hr. Biotinylated CpG-B was recovered on streptavidin beads, and bound materials were immunoblotted with anti-Myc. Immunoprecipitates were treated with Endo F. (B) The C-terminal TLR9 fragment transcribed and translated in vitro in the presence of microsomes and [35S]methionine binds CpG-ODNs. Microsomes were pelleted and lysed. Biotinylated CpG-B (3 μM) and the indicated concentration of purified granulin were incubated for 2 hr at 37°C,  followed by incubation with streptavidin beads. Biotinylated CpG-B ODNs were recovered by streptavidin beads, and then binding of TLR9 to CpG-B ODNs was examined by reimmunoprecipitation with anti-Myc. (C) Age-matched wild-type and Grn–/– mice were injected intraperitoneally with CpG-B ODNs (5 nmol). Sera of CpG-B ODN-injected mice were taken at 2 and 4 hr after injection. Serum concentrations of TNF-α and IL-6 were measured by ELISA. Results show mean ± SD of serum samples from three mice. Data are representative of two independent experiments. Immunity 2011 34, 505-513DOI: (10.1016/j.immuni.2011.01.018) Copyright © 2011 Elsevier Inc. Terms and Conditions